Modern herbal medicines in the treatment of acute rhinosinusitis
https://doi.org/10.21518/2079-701X-2018-8-98-102
Abstract
Acute rhinitis (ICD-X, acute nasopharyngitis, runny nose – J00) and acute sinusitis (J01) make up a larger proportion of all acute upper respiratory tract diseases (J00-J06). The prescription of antibacterial drugs for the treatment of virus diseases in the ENT area and the unproven or unconfirmed bacterial disease is considered erroneous and dangerous. In this regard, the role of pathogenetically justified therapy in the treatment of ARS increases. When choosing the medicines for ARS, particular attention is given to the use of herbal medicines with combination effect, which found its way into legislation – a group of herbal medicines is included in the list of ARS treatment medicines in adults in the EPOS-2012 document, and methodological recommendations approved by the National Medical Association of Otorhinolaryngologists.
About the Authors
S. A. Artyushkin
North-Western State Medical University of the Ministry of Health of Russia, St. Petersburg
Russian Federation
MD, Prof.
Russian Federation
MD, Prof.
S. V. Ryazantsev
Saint-Petersburg Research Institute of Ear, Throat, Nose and Speech of the Ministry of Health of Russia
Russian Federation
MD, Prof.
Russian Federation
MD, Prof.
N. V. Eremina
North-Western State Medical University of the Ministry of Health of Russia, St. Petersburg
Russian Federation
MD, Prof.
Russian Federation
MD, Prof.
S. A. Eremin
Saint-Petersburg Research Institute of Ear, Throat, Nose and Speech of the Ministry of Health of Russia
Russian Federation
PhD in medicine
Russian Federation
PhD in medicine
References
1. Piskunov GZ, Piskunov SZ. Clinical rhinology. M.: Miklos, 2002. 390 p.
2. Karpova, EP. Rhinosinusitis or a “banal cold” in children. Lechashchiy Vrach, 2016, 12 (special impression): 1-7. wwwlvrach.ru.
3. Maniglia AJ, Goodwin WJ, Arnild JE et al. Intracranial abscesses secondary to nasal, sinus, and orbital infections in adults and children. Arch. Otolaryngol Head Neck Surg, 1989, 115: 1424-1429.
4. Ryazantsev SV, Konoplev OI, Krivopalov AA, Shatalov VA. Mukoactive therapy for acute sinusitis using a carbocysteine lysine salt-containing drug. Meditsinsky Sovet, 2015, 11: 27-30.
5. Fokkens WJ, Lund VJ, Mullol J, Bachert C, Alobid I, Baroody F, et al. European Position Paper on Rhinosinusitis and Nasal Polyps. Rhinol Suppl, 2012 Mar, 23: 40-41.
6. Beuscher N, Keitzmann M, Bien E, Champeroux P. Interference of Myrtol standardized with inflammatory and allergic mediators. Arzneimittelforschung, 1998, 48: 985-989.
7. Sanchez GV, Hicks LA. Acute sinusitis and pharyngitis as inappropriate indications for antibiotic use. Antimicrob Agents Chemother, 2014, 58: 3572.
8. Acute sinusitis: methodological recommendations. Edited by Ryazantsev SV. SPb.: Poliforum Group, 2017. 32 p.
9. Federal clinical guidelines for the provision of medical care to children with acute respiratory viral infection (acute nasopharyngitis). Ministry of Health of the Russian Federation, Union of Pediatricians of Russia, 2015. 12 p.
10. Acute respiratory viral infections in adults: Clinical guidelines. Approved by the Order of the Plenum of the Board of Nat. Sci. Society of Infectious Diseases of Oct. 30, 2014, 2014. 69 p.
11. Karneeva OV, Ryazantsev SV, Radtsig EYu, Kim IA. Therapeutic potential of clinical homeopathy in the combination therapy of acute inflam matory diseases of the upper respiratory tract: Method. recommendations. M.; SPb., 2017. 40 p.
12. Tets VV, Nakatis YaA. Infections of pharynx, nose, ear. Ch. 3. Microorganisms and antibiotics. Infections in otorhinolaryngology. St. Petersburg: KLE-T, 2009: 49-115.
13. Kenealy T, Arroll B. Antibiotics for the common cold and acute purelent rhinitis. Cochrane Database Syst Rev, 2013, 6: CD000247.
14. Savenkova MS. The many faces of acute respiratory infection: from the main pathogens to the choice of drugs. Lechashchiy Vrach, 2011, 3: 58-64.
15. Zaitseva SV, Zaitseva OV. Acute respiratory infections in children: the etiopathogenetic potential of modern therapy. Meditsinsky Sovet, 2014, 5: 22-30.
16. Dvoretsky LI. Treatment of patients with acute respiratory diseases: is there an alternative to polypragmasy? Consylium Medicum, 2008, 10 (10): 10-14.
17. Klyuchnikov SO. Polypragmasy: ways to solve the problem. Detskie Infektsii, 2014, 4: 36-39.
18. Wittig T. Myrtol standardized. Clinical documentation, Russia, 2009, 1 st ed., ISBN 3-8796-071-6: 22-45.
19. Lai Y, Dilidaer D, Chen B, Xu G, Shi J, Lee RJ, Cohen NA. In vitro studies of a distillate of rectified essential oils on sinonasal components of mucociliary clearance. American journal of rhinology and allergy, 2014, 28(3): 244-248.
20. Grassmann J, Hipelli S, Dornisch K, Rohnert U, Beuscher N, Elstner EF. Antioxidant Properties Of Essential Oils. Possible explanations for their anti-inflammatory effects. Arzneimittelforschung, 2000, 50(02): 135-139.
21. Christoph F, Kaulfers P, Stahl-Biskup E. In vitro Evaluation of the Antibacterial Activity of β-Triketones Admixed to Melaleuca Oils. Planta Med, 2001, 67(08): 768-771.
22. Federspil P, Wulkow R, Zimmermann T. Effects of standardized Myrtol in therapy of acute sinusitis–results of a double - blind, rand-omized multicenter study compared with placebo. Laryngorhinootologie, 1997 Jan, 76(1): 23-7.
23. Karpova EP, Emelyanova MP, Tulupov DA. Standardized herbal medicines in the treatment of acute rhinosinusitis in children. Pediatriya Im. G.N. Speranskogo, 2016, 95 (1): 97-105.
24. Order of the Ministry of Health of the Russian Federation No. 1201 of December 20, 2012 Approval of the Standard for Primary Health Care for Acute Sinusitis.
25. Abdulkerimov KhT, Garashchenko TI, Koshel VI, Ryazantsev SV, Svistushkin VМ. Principles of the etiopathogenetic therapy of acute sinusitis: methodological recommendations. SPb.: Poliforum Group, 2015: 35-36.
Review
For citations:
Artyushkin SA, Ryazantsev SV, Eremina NV, Eremin SA. Modern herbal medicines in the treatment of acute rhinosinusitis. Meditsinskiy sovet = Medical Council. 2018;(8):98-102. (In Russ.) https://doi.org/10.21518/2079-701X-2018-8-98-102
Views:
615
Email this article 